Thoracic metastasectomy for nonseminomatous germ cell tumors

Journal of Thoracic Oncology

Volumn 5, Issue 6 SUPPL. 2, 2010, Pages

  Pfannschmidt, Joachim ^a   Hoffmann, Hans ^a   Dienemann, Hendrick ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Nonseminomatous germ cell tumor; Pulmonary metastases; Surgery

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; CISPLATIN DERIVATIVE; TUMOR MARKER;

CANCER ADJUVANT THERAPY; EVIDENCE BASED MEDICINE; HISTOLOGY; HUMAN; LUNG METASTASIS; LUNG RESECTION; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; MORTALITY; NON SEMINOMATOUS GERMINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT INDICATION; BLOOD; LUNG NEOPLASMS; NEOPLASMS, GERM CELL AND EMBRYONAL; SECONDARY;

HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; PNEUMONECTOMY; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953144707     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181dcf908     Document Type: Article

References (33)

1. Bleyer A, O'Leary M, Barr R, et al. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000, NIH Pub. No. 06-5767. Bethesda, MD: National Cancer Institute, 2006.
2. Sharir S, Foster RS, Donohue JP, et al. What is the appropriate follow-up after treatment? Semin Urol Oncol 1996;14:45-53.
3. Vergouwe Y, Steyerberg EW, Eijkemans MJ, et al. Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review. J Clin Oncol 2003;21:4092-4099.
4. Liu D, Abolhoda A, Burt ME, et al. Pulmonary metastasectomy for testicular germ cell tumors: a 28-year experience. Ann Thorac Surg 1998;66:1709-1714.
5. Bosl GJ, Sheinfeld J, Bajorin DF, et al. Cancer of the testis. In: Devita V Jr, Hellman S, Rosenberg SA (Eds.). Cancer, Principles and Practice of Oncology, 7th Ed. Philadelphia: Lippincott Williams & Wilkins, 2005.
6. Fizazi K, Tjulandin S, Salvioni R, et al. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy-results from an international study group. J Clin Oncol 2001;19:2647-2657.
7. Oldenburg J, Alfsen GC, Lien HH, et al. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol 2003;21:3310-3317.
8. Johnston M, De Perrot M: Metastatic cancer to the lung. In: Devita V Jr, Hellman S, Rosenberg SA, (Eds.). Cancer, Principles and Practice of Oncology, 7th Ed. Philadelphia: Lippincott Williams & Wilkins, 2005.
9. Besse B, Grunenwald D, Flechon A, et al. Nonseminomatous germ cell tumors: assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis. J Thorac Cardiovasc Surg 2009;137:448-452.
10. Cagini L, Nicholson AG, Horwich A, et al. Thoracic metastasectomy for germ cell tumours: long term survival and prognostic factors. Ann Oncol 1998;9:1185-1191.
11. Kesler KA, Wilson JL, Cosgrove JA, et al. Surgical salvage therapy for malignant intrathoracic metastases from nonseminomatous germ cell cancer of testicular origin: analysis of a single-institution experience. J Thorac Cardiovasc Surg 2005;130:408-415.
12. McGuire MS, Rabbani F, Mohseni H, et al. The role of thoracotomy in managing postchemotherapy residual thoracic masses in patients with nonseminomatous germ cell tumours. BJU Int 2003;91:469-473.
13. Pfannschmidt J, Zabeck H, Muley T, et al. Pulmonary metastasectomy following chemotherapy in patients with testicular tumors: experience in 52 patients. Thorac Cardiovasc Surg 2006;54:484-488.
14. Anyanwu E, Krysa S, Buelzebruck H, et al. Pulmonary metastasectomy as secondary treatment for testicular tumors. Ann Thorac Surg 1994;57:1222-1228.
15. Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997;113:37-49.
16. Gels ME, Hoekstra HJ, Sleijfer DT, et al. Thoracotomy for postchemotherapy resection of pulmonary residual tumor mass in patients with nonseminomatous testicular germ cell tumors: aggressive surgical resection is justified. Chest 1997;112:967-973.
17. Ahmed T, Bosl GJ, Hajdu SI. Teratoma with malignant transformation in germ cell tumors in men. Cancer 1985;56:860-863.
18. Logothetis CJ, Samuels ML, Trindade A, et al. The growing teratoma syndrome. Cancer 1982;50:1629-1635.
19. Hendry WF, Norman AR, Dearnaley DP, et al. Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses. Cancer 2002;94:1668-1676.
20. Einhorn LH, Williams SD, Mandelbaum I, et al. Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 1981;48:904-908.
21. Stenning SP, Parkinson MC, Fisher C, et al. Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party. Cancer 1998;83:1409-1419.
22. Harding MJ, Brown IL, MacPherson SG, et al. Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours. Eur J Cancer Clin Oncol 1989;25:1689-1694.
23. Fox EP, Weathers TD, Williams SD, et al. Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections. J Clin Oncol 1993;11:1294-1299.
24. Steyerberg EW, Keizer HJ, Zwartendijk J, et al. Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis. Br J Cancer 1993;68:195-200.
25. Sheinfeld J, Bajorin D. Management of the postchemotherapy residual mass. Urol Clin North Am 1993;20:133-143.
26. Pizzocaro G, Nicolai N, Milani A. Is further chemotherapy necessary in radically resected residual cancer in non-seminomatous germ cell tumors (NSGCT) of the testis following induction chemotherapy? Proc Am Soc Clin Oncol 1998;17:309a (abstr 1191).
27. Habuchi T, Kamoto T, Hara I, et al. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers. Cancer 2003;98:1635-1642.
28. Hartmann JT, Candelaria M, Kuczyk MA, et al. Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours. Eur J Cancer 1997;33:843-847.
29. Steyerberg EW, Keizer HJ, Messemer JE, et al. Residual pulmonary masses after chemotherapy for metastatic nonseminomatous germ cell tumor. Prediction of histology. ReHiT Study Group. Cancer 1997;79:345-355.
30. Stephens AW, Gonin R, Hutchins GD, et al. Positron emission tomography evaluation of residual radiographic abnormalities in postchemotherapy germ cell tumor patients. J Clin Oncol 1996;14:1637-1641.
31. Johns Putra L, Lawrentschuk N, Ballok Z, et al. 18F-fluorodeoxyglucose positron emission tomography in evaluation of germ cell tumor after chemotherapy. Urology 2004;64:1202-1207.
32. Kollmannsberger C, Oechsle K, Dohmen BM, et al. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma. Cancer 2002;94:2353-2362.
33. Fizazi K, Prow DM, Do KA, et al. Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours. Br J Cancer 2002;86:1555-1560.